User profiles for Jeffrey H. Meyer

Jeffrey Meyer

Verified email at camhpet.ca
Cited by 18235

Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression

…, S Krüger, HS Mayberg, JH Meyer… - American Journal of …, 2001 - Am Psychiatric Assoc
OBJECTIVE: Depression is commonly associated with frontal hypometabolic activity
accompanied by hypermetabolism in certain limbic regions. It is unclear whether successful …

Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes

…, JL Kennedy, PV Rekkas, S Houle, JH Meyer - JAMA …, 2015 - jamanetwork.com
Importance The neuroinflammatory hypothesis of major depressive disorder is supported by
several main findings. First, in humans and animals, activation of the immune system …

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression

JH Meyer, N Ginovart, A Boovariwala… - Archives of general …, 2006 - jamanetwork.com
Context The monoamine theory of depression proposes that monoamine levels are lowered,
but there is no explanation for how monoamine loss occurs. Monoamine oxidase A (MAO-A…

Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [11C]DASB Positron Emission Tomography Study

JH Meyer, AA Wilson, S Sagrati… - American Journal of …, 2004 - Am Psychiatric Assoc
OBJECTIVE: Minimum therapeutic doses of paroxetine and citalopram produce 80%
occupancy for the serotonin (5-HT) transporter (5-HTT). The authors used [ 11 C]DASB positron …

Smoking-induced ventral striatum dopamine release

…, ED London, J Farahi, JH Meyer… - American Journal of …, 2004 - Am Psychiatric Assoc
OBJECTIVE: Substantial evidence from animal models demonstrates that dopamine release
in the ventral striatum underlies the reinforcing properties of nicotine. The authors used [ 11 …

Occupancy of Serotonin Transporters by Paroxetine and Citalopram During Treatment of Depression: A [11C]DASB PET Imaging Study

JH Meyer, AA Wilson, N Ginovart… - American Journal of …, 2001 - Am Psychiatric Assoc
OBJECTIVE: Selective serotonin reuptake inhibitors are commonly used to treat major
depression; however, the percentage of serotonin (5-HT) transporter (5-HTT) sites occupied …

Lower dopamine transporter binding potential in striatum during depression

JH Meyer, S Krüger, AA Wilson, BK Christensen… - …, 2001 - journals.lww.com
Previous studies suggest that there is a dopamine lowering process during major depressive
episodes (MDE). To investigate this, we measured the dopamine transporter binding …

Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin

…, F Benedetti, A Halaris, JH Meyer, H Stassen… - The Lancet …, 2020 - thelancet.com
There is increasing recognition in the neurological and psychiatric literature of patients with
so-called isolated psychotic presentations (ie, with no, or minimal, neurological features) …

Dysfunctional Attitudes and 5-HT2 Receptors During Depression and Self-Harm

JH Meyer, S McMain, SH Kennedy… - American journal of …, 2003 - Am Psychiatric Assoc
OBJECTIVE: Dysfunctional attitudes are negatively biased assumptions and beliefs
regarding oneself, the world, and the future. In healthy subjects, increasing serotonin (5-HT) …

Imaging the serotonin transporter during major depressive disorder and antidepressant treatment: 2005 CCNP Young Investigator Award Paper

JH Meyer - Journal of Psychiatry and Neuroscience, 2007 - jpn.ca
This paper focuses on serotonin transporter 5-HTT imaging to investigate major depressive
disorder (MDD) and antidepressant occupancy. Such investigations have only recently been …